You are here: Industry Insights > Amsterdam

News List

Bristol Myers Squibb Invests in Cell Therapy Ops contractpharma
April 28, 2021
Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing life sciences region near Amsterdam and convenient access to transportation for shipping patient cells.
Bluebird’s Zynteglo kicks off first Amsterdam CHMP recommendations pharmatimes
April 02, 2019
The first Amsterdam-based European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) meeting has been held, resulting in just one new initial marketing authorisation and three label extensions.
EMA set for official move from London on 1 March pharmaphorum
January 25, 2019
The European Medicines Agency (EMA) has officially taken over its new building in Amsterdam in preparation of its move to the Dutch capital from London.
Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected pharmafile
September 20, 2018
Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, according to Dutch regional public...
Novartis moving 400 employees to Amsterdam fiercepharma
September 20, 2018
After more than 50 years in Arnhem, the Netherlands, Novartis has decided to move its Dutch operations to Amsterdam, the new home of the European Medicines Agency (EMA).
EMA discusses future Amsterdam premises europeanpharmaceuticalreview
February 08, 2018
The EMA Management Board have met in an extraordinary session to discuss EMA’s future premises in Amsterdam…
Amsterdam beats out Milan to host EMA fiercebiotech
November 22, 2017
Amsterdam will be the post-Brexit home of the European Medicines Agency, a decision made via drawing lots after the vote between the final two contenders came down to a tie.
EMA to Relocate to Amsterdam, the Netherlands americanpharmaceuticacreview
November 22, 2017
The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands. This decision was taken today by the EU 27 Member States in the margins of the General Affairs Council.
EMA to change relocation to Amsterdam in the Netherlands europeanpharmaceuticalreview
November 21, 2017
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest.